Current evidence shows the safety risks of poorly sourced compounded GLP-1s
Patients who actively combine their Semaglutide treatment with mindful nutritional changes, adequate hydration, and regular physical activity see the most profound and lasting results
GLP-1s approved for diabetes include Mounjaro (tirzepatide), Ozempic (semaglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), and Victoza (liraglutide)
Storebo OJ, Ramstad E, Krogh HB, et al
Without insurance, list prices in 2026 are roughly: Wegovy $1,349 per month, Zepbound $1,086 per month (auto-injector) or $349 to $549 (vials through LillyDirect), Ozempic $998 per month, Mounjaro $1,069 per month